162 related articles for article (PubMed ID: 8856146)
1. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
[No Abstract] [Full Text] [Related]
3. A new class of potent bradykinin antagonist dimers.
Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
[No Abstract] [Full Text] [Related]
4. New bradykinin antagonists having very high potency at B1 receptors.
Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
[No Abstract] [Full Text] [Related]
5. Inducible bradykinin B1 receptor in isolated human ileum.
Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):113-5. PubMed ID: 8856127
[No Abstract] [Full Text] [Related]
6. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
8. A new generation of bradykinin antagonists.
Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
[TBL] [Abstract][Full Text] [Related]
9. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
10. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
11. A new class of bradykinin antagonists containing indanylglycine.
Gera L; Stewart JM
Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
[No Abstract] [Full Text] [Related]
12. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
13. Non-selectivity of new bradykinin antagonists for B1 receptors.
Rhaleb NE; Gobeil F; Regoli D
Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
[TBL] [Abstract][Full Text] [Related]
14. Potent, long-acting bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
[TBL] [Abstract][Full Text] [Related]
15. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
[TBL] [Abstract][Full Text] [Related]
17. Antagonists for kinin B1 and B2 receptors in the mouse.
Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
[TBL] [Abstract][Full Text] [Related]
18. Receptors for kinins: from classical pharmacology to molecular biology.
Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
[TBL] [Abstract][Full Text] [Related]
19. DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.
Wirth KJ; Wiemer G; Schölkens BA
Agents Actions Suppl; 1992; 38 ( Pt 2)():406-13. PubMed ID: 1334341
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors.
Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
Fundam Clin Pharmacol; 1999; 13(1):75-83. PubMed ID: 10027091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
